Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

21-30 of 84 results

Catalogue Number:

DA035

Category:

G

Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5)

Target: 2019-nCoV Spike
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Mouse IgG1
Host Species: Mouse
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

DA043

Category:

G

Anti-2019-nCoV S-RBD Antibody (9B2)

Target: 2019-nCoV S-RBD
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Human IgG1
Host Species: Human
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

DA032

Category:

G

Anti-2019-nCoV Spike mAb (IgG&IgM Positive Control)

Target: 2019-nCoV Spike
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotypes/Mimetics: Human IgG, Human IgM
Host Species: Human
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH7.4
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

NC083

Category:

G

Anti-MPXV A35R mAb

Target: MPXV A35R
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Human IgG1
Host Species: Human
Formulation: Supplied as a 0.2 μm filtered solution of 50mM Sodium Citrate, 8%Sucrose, 0.06%Tween80, 10%Glycerol, pH6.0.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

NC082

Category:

G

Anti-MPXV B6R mAb

Target: MPXV B6R
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Human IgG1
Host Species: Human
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

DA120

Category:

G

CSFV E2 Antibody (5D11)

Target: CSFV E2
Species Reactivity: Other
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Mouse IgG1
Host Species: Mouse
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

DA091FDL

Category:

G

FITC RSV F Antibody (11A9), Epitope II

Target: RSV F
Species Reactivity: Human
Application: Flow Cytometry
Type: Primary Recombinant
Isotype/Mimetic: Human IgG1
Host Species: Human
Conjugate: FITC
Formulation: Supplied as a 0.2 μm filtered solution of 10mM PBS, 0.1% BSA, 0.1%ProClin300, pH7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

DA101FDL

Category:

G

FITC RSV Pre-F Antibody (3C12), Epitope Φ

Target: RSV Pre-F
Species Reactivity: Human
Application: Flow Cytometry
Type: Primary Recombinant
Isotype/Mimetic: Human IgG1
Host Species: Human
Conjugate: FITC
Formulation: Supplied as a 0.2 μm filtered solution of 10mM PBS, 0.1% BSA, 0.1% ProClin300, pH7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

DA104

Category:

G

Flu A NP Antibody (5H8)

Target: FluA NP
Species Reactivity: Human
Application: ELISA
Other Application: Immunochromatography.
Type: Primary Recombinant
Isotype/Mimetic: Mouse IgG1
Host Species: Mouse
Formulation: Supplied as a 0.2 μm filtered solution of 20mM PB, 8% Sucrose, 100mM NaCl, 10% Glycerol, 0.05% Tween80, 0.02% Tween20, pH7.5.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Antibody display library from animal blood draw
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

DA077

Category:

G

FluA HA antibody (8F10)

Target: FluA HA
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: Mouse IgG1
Host Species: Mouse
Formulation: Supplied as a 0.2 μm filtered solution of PBS, pH7.4.
Animal-Derived Biomaterials Used: No
Sequence Available Yes
Original Discovery Method Unknown
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation